The authors represent a cooperative group of 15 institutions that examined the feasibility of using metabolic fea tures observed in vivo with 'H-magnetic resonance (MR) spectroscopy to characterize brain tumors of the glial type.
brain. Choline signal intensities were highest in astrocytomas and anaplastic astrocytomas, and creatine signal intensi ties were lowest in glioblastomas. However, whether expressed relative to brain or as intratumoral ratios, these meta bolic characteristics exhibited large variations within each subtype of glial tumor. The resulting overlaps precluded diagnostic accuracy in the distinction of low-and high-grade tumors. Although the extent of contamination of the ]H-MR spectroscopy voxel by brain had a marked effect on metabolite concentrations and ratios, selection of cases with minimal contamination did not reduce these overlaps. Thus, each type and grade of tumor is a metabolically hetero geneous group. Lactate occurred infrequently and in all grades. Mobile lipids, on the other hand, occurred in 41% of high-grade tumors with higher mean amounts found in glioblastomas. This result, coupled with the recent demonstra tion that intratumoral mobile lipids correlate with microscopic tumor cell necrosis, leads to the hypothesis that mobile lipids observed in vivo in E H-MR spectroscopy may correlate independently with prognosis of individual patients. K ey W ords • b ra in neoplasm • glioma • m agnetic resonance spectroscopy • lipids • m etabolite T he prognostic significance of histopathological and molecular biological factors in brain tumors is of interest because these factors are potentially able to guide clinical management decisions. 32 The association b etw een poor survival of patients with glial tumors and g lu co se hypermetabolism determined by positron em is s io n tomography (PET) i> 2^25< 44'56 raised interest in exam in in g correlations between visualizable in vivo metabolic featu res and prognosis in brain tumors. Recently, proton ]H-nuclear magnetic resonance (NMR) spectroscopy has also been applied to study metabolic aspects of brain tumors. Nuclear magnetic resonance spectroscopy uses radiofrequency excitation in the presence o f a m agnetic field to obtain signals from naturally occurring 'H nuclei to identify and quantitate metabolites. The m ost co m monly acquired 'H-NMR spectra of brain have three major peaks, one containing primarily signals from ch o lines (choline, phosphorylcholine, and glycerophospho-J, Neurosurg. / Volume 84 / March, 1996 4 4 9 W. G. Negendank, et ciL rylcholine), one primarily from creatines (creatine and phosphocreatine), and one primarily from acetyl aspar tate (NAA), In disease, signals from lactate and mobile lipids may also be observed.
Studies of extracts of surgical specimens of human as trocytic tum ors using ]H -N M R spectroscopy indicated an increase in the ratio o f cholines to creatines, and a decrease in the ratio of N A A to creatines, with increas ing histopathological grades of m alignancy. 16,45'61 Studies in patients using !H-N M R spectroscopy, referred to as MR spectroscopy, indicated sim ilar correlations betw een m etabolic features in vivo and the histopathological grades of astrocytic tum ors.4 '11'14'21,32,43'57'58'61 Other MR spectroscopy studies indicated that lactate is more likely to be present in high-than in low-grade tumors4, 14,15'20'21 and that the am ount of lactate may correlate with the extent of hyperm etabolic glucose consumption shown in PET 2, 14, 22 In a recent study, lipids w ere recognized in vivo in 23% of spec t o from 48 gliomas and the authors sug gested that these lipids occur with higher incidence in tumors of higher histopathological grade;43 this agrees with the finding in intact surgical specimens that higher grade astrocytic tumors contain mobile lipids, the amounts of which correlate with the amount of microscopic cellu lar necrosis.31
In all published studies, metabolic signal intensities had large coefficients of variation within, and overlaps be tween, histopathological grades o f glial tumors. M ore over, trends in metabolic changes among different grades were inconsistent. For example, in some studies the cho line/creatine ratio did not progressively increase with in creasing grade,11,14,32 and in some the level o f NAA did not progressively decrease with increasing grade but was higher in high grades than in intermediate ones or in inter mediate grades com pared to low ones 4, 11, 32, 43, 57, 61 The vari ations and overlaps have precluded diagnostic use o f 1H-M R spectroscopy to distinguish grades o f glial tumors. Factors that may contribute to this and to different results from different studies include: nonuniformity o f histo pathological grading systems; spatial variations in grading within a tumor; nonuniformity o f techniques used to local ize ^-N M R spectra to the region o f interest; and variable attempts to avoid contam ination o f spectra by metabolites from edematous brain and obvious non viable regions of tumors. Different ^-M R spectroscopy acquisition param eters, in particular, different echo and repetition times, modulate metabolite signal intensities in different ways. Finally, the identification and quantitation o f lipids in vivo requires methods that perm it distinction between intratumoral lipids and contam inant lipid signals from the skull or scalp and between lipid and lactate signals that overlap one another.
To attem pt to overcome some o f these limitations, ac crue a sizable num ber of patients with different grades of glial tumors in a short time, and define m ore accurately the potential o f in vivo single-voxel !H -M R spectroscopy to characterize primary brain tumors, we organized a cooperative group consisting of 15 institutions using iden tical acquisition techniques in similar clinical instruments. Our study, prelim inary accounts o f which have been pre sented elsew here,39,40 provides blinded uniform MR spec troscopy data processing at a central location, uniform histopathological typing, uniform criteria for case selec tion, and quantitation of lipids and lactate.
Clinical Material and Methods

Establishment o f the Cooperative Group and Technical Quality-Control Procedures
Institutional eligibility required: 1) a Siemens 1.5-tesla magnetic field-strength M agnetom SP with A2.3 software and a circularly polarized head coil; 2) a standard 'H-MR spectroscopy protocol; and 3) the ability to meet quality-control criteria established in a preceding study. In the preceding study spectra were obtained using a spinecho technique7 from nominal 8-cc voxels in parietooc cipital lobes and basal ganglia of six volunteers at each of 38 institutions.53 Technical quality-control procedures per formed on phantoms and volunteers included calibration of transmitter adjustment, global shimming to adjust for static Bo inhomogeneity, eddy current adjustments, local shimming to adjust for local static and dynamic Bo inho mogeneity, and calibration of water suppression. The first criterion for acceptance of MR spectroscopy data from an individual case included absence of any artifacts resulting from miscalibration or misadjustment of shimming, eddycurrent correction, or water suppression, which interfere with analysis of metabolite intensities. The second criteri on was an adequate signal-to-noise ratio to permit repro ducible peak area integration. The third criterion, applica ble to NM R spectra from voxels placed near the skull, was absence of contaminating lipid signals, which overlap or distort other peaks in the spectrum.
Patient Selection
Patients of any age with newly diagnosed or recurrent primary brain tumors of the glial subtype were examined. The initial criteria for inclusion in this study were: 1) acceptable quality of the spectrum; 2) evidence on M R imaging of a tumor occupying at least half the volume of the 8-cc M R spectroscopy voxel; and 3) histological con firmation of the diagnosis at some time in the course of the disease. We accepted recurrent cases if they had adequate objective clinical evidence of recurrence of tumor includ ing rebiopsy and/or diagnostic MR imaging and com pu terized tomography scans. We included four cases with a clinical diagnosis of astrocytoma that was made without a biopsy because they had typical clinical and MR im aging features and a biopsy could have caused unnecessary brainstem damage.
Data Flow, Database, and Evaluation
M agnetic resonance imaging, histological, clinical, and demographic data were submitted to Fox Chase Cancer Center for central review. The algorithm by which cases were evaluated and included or excluded from analysis is summarized in Fig. 1 .
Clinical MR imaging studies were required to m eet the following criteria: 1 ) images had to be produced in at least two planes to permit accurate definition of the M R spec troscopy voxel placement; 2) images had to be sufficient to permit an independent outside observer to assess the presence of a solid, apparently viable tumor and the voxel placem ent relative to it; and 3) images had to be submit te d for central review. The compositions of the M R spec troscopy voxels were assessed independently using all available MR imaging studies and expressed as fractions o f solid tumor, edematous brain, nonedematous brain, liquefaction necrosis, cystic hemorrhagic necrosis, simple cysts, surgical cystic defects, ventricle, and extramedullary tissue (for example, skull). The region o f solid tu m o r was often readily apparent in a combination o f stan d ard Tj-and T2-weighted images. However, in accordance w ith recent experience,19 we found that for m any astrocyt ic tumors and for most tumors that recurred after prior treatm ent, contrast enhancement was necessary to define th e location and extent of apparently viable tumor and to differentiate it from cystic necrosis and edematous brain. T h e ratio of the volume of solid tumor to that o f solid tum or plus brain (tumor/tumor + brain) was calculated an d is referred to as the "tumor fraction." In this expres sion, the term "tumor" is used only to describe solid tumor, not cystic or necrotic regions, and the term "brain" includes edematous and nonedematous brain. We accept ed any case with an estimated tum or fraction in the 8-cc MR spectroscopy voxel greater than 0.5, because we did not know a priori the extent to which contam ination o f the spectrum with metabolites in brain would affect th e abili ty of ]H-MR spectroscopy to characterize tumors.
Histopathology reports were reviewed independently at Fox Chase Cancer Center to ascertain the diagnosis and to confirm typing of glial tumors according to the current World Health Organization (WHO) classification:27 as trocytic tumors, oligodendrogliomas, and ependym om as. Astrocytic tumors were subclassified according to in creasing grade o f malignancy as astrocytoma (A S), ana plastic astrocytoma (AA), and glioblastoma m ultiform e (GBM). In approximately two-thirds of the cases, p ath o l ogists used this classification explicitly. In the rem ain der, the previous WHO or other classifications that used numerical grading (I-IV) were used. However, typical GBM and typical low-grade AS were readily identified. Thus, less than 10% of astrocytic tumors originally had been designated "Grade III" or "Grade III-IV" and re quired reassignment to current WHO typing. If there w as any necrosis or vascular proliferation within tum or-con taining regions in the microscopic description, the case was designated GBM. Four cases in which current W H O typing was not used and whose microscopic description was inadequate to permit independent assignm ent w ere excluded from further analysis.
Recurrent tumor cases were evaluated to ascertain inde pendently the strength of the evidence for recurrence and, in cases previously treated, the ability to separate the region of tumor from regions of radiation or surgical damage. Information used to make these judgm ents in cluded the MR imaging studies (with and without contrast enhancement), computerized tomography scans, and re cently repeated biopsies. If objective evidence for recur rent tumor could not be ascertained, the case was exclud ed from further analysis.
Proton lH-Magnetic Resonance Spectroscopy
Scout M R images using fast low-angle shot (F L A S H ) 18 were obtained in two or three planes through the brain to define the region of placement of 8-cc M R spectroscopy voxels. Voxels were placed to maximize their content o f viable tumor. Necrotic or cystic regions of tumors w ere avoided when possible but were included in the voxel if necessary to limit brain contamination. W herever feasible, 'H-NM R spectra were obtained both from the tum or and the mirror-image region in the contralateral brain. G lobal and localized shimming on the water proton w as p er formed to obtain less than 25 Hz and 10 Hz full w idth at half-maximum, respectively, from brain. Spectra w ere localized using the spin-echo method7 along with chem i cal shift selective water suppression.17 A single-voxel method, rather than multivoxel chemical shift im aging, was selected because of the feasibility of im plem entation in clinical imagers at multiple institutions. The spin-echo method was selected based partly because of its signal-tonoise advantage over the stimulated echo m ethod.37 T he advantages and limitations of this method have been d is cussed.48,55 Different regions of the spectrum have signals emitting from slightly different voxels: those of cholines at 3.2 ppm are from a voxel whose dimensions are each shifted approximately 10% relative to those of lipids at 7. Neurosurg. / Volume 84 / March, 1996 0.9 ppm. Chemical shift dispersion reduces the effective voxel size for lactate to 5.6 ml when the nominal voxel size for singlet resonances is 8 ml. This, along with im per fections in rectangular slice profiles and effects of m ulti ple quantum coherences by variations in pulse angles, results in approximately a 50% reduction in sensitivity of the spin-echo method for lactate. Two-hundred fifty-six acquisitions were obtained with an echo time of 135 m sec and a repetition time of 1600 msec to give a total M R spectroscopy acquisition time of 6.5 minutes. The echo tim e of 135 msec was used so that, relative to the rem ainder o f the spectrum, lactate methyl proton signals would be 180° out o f phase whereas intratumoral lipid m ethylene proton signals (which overlap lactate at 1.3 ppm) would be in phase. Phase distortions in the water-suppressed !H -N M R spectrum caused by eddy currents were rem oved by taking a nonsuppressed water reference signal acquired with the same M R spectroscopy sequence and calculating a phase transformation factor, permitting one to set the phase angle to zero for each time point.28,42 The JH -M R spectroscopy procedure is illustrat ed in Fig. 2 , in which M R spectroscopy voxel positions are overlaid on scout M R images and spectra from tum or and brain are shown.
Analysis o f Data From MR Spectroscopy
Digital M R spectroscopy data w ere submitted for blind ed analysis to Siemens, A G (Erlangen, Germany). Peak areas were determined by m anual integration using Sie mens Num aris software. Peaks w ere assigned according to their positions relative to water at 4.7 ppm and m etabo lite identification in vitro,3126,49 Brain spectra ( Fig. 2 ) con tain four peaks: one primarily from the N-trimethyl pro tons of choline-containing metabolites at 3.2 ppm, one from the //-m ethyl protons of creatines at 3.0 ppm, a smaller one from the methylene protons of creatine at 3.9 ppm, and one primarily from the methyl protons of NAA at 2.0 ppm. N-acetylaspartate is within neurons and therefore is decreased whenever the brain is damaged or replaced. In tumors the peak around 2.0 ppm may then contain larger fractions of metabolites present in con centrations normally much lower than that of N A A , including N-acetyl-aspartylglutamate, glutamine, gluta mate, and 7 -aminobutyiic acid. Therefore, in tumors we refer to the "NAA region" rather than to "NAA."
The M R spectroscopy data are presented in two ways. First, the peak area intensity of the signal of each m etabo lite in the tumor was expressed as a ratio to the intensity of creatines in contralateral brain. Assuming brain cre atines to be an appropriate reference and ignoring any possible saturation effects, this permits estimation of the extent to which metabolite concentrations are altered in tumors. Second, peak area intensities of intratum oral metabolites were expressed as ratios to one another and compared to the same ratios in contralateral brain and in other tumor types. Mean ratios were compared betw een groups by nonparametric tests to take into account non normal distributions within some of the groups. The M ann-W hitney U-test was used for nonpaired group com parisons and the Wilcoxon signed-rank test for paired 
Results
Fifteen institutions studied 113 patients with glial tu m ors over approximately 1 year. Application of the eval uation algorithm (Fig. 1 ) resulted in the exclusion of 27 cases (Table 1) Table  2 . Thirteen glial tumors were found in children (<18 years old); nine of these tumors were astrocytic and four w ere ependymomas. O f 55 newly diagnosed cases, only seven patients had had biopsy before M R spectroscopy w as performed. Of 31 recurrent tumors, 25 had previous ly been treated with radiation therapy.
The effect of voxel contamination on the ratios of the levels of cholines, creatines, and the NAA region in astro cytic tumors to those of the corresponding metabolites in b rain is shown in Fig. 3 . As expected, the mean intensity o f the NAA region in tumors relative to that in the con tralateral brain decreased progressively with decreasing brain contamination. The mean intensity o f creatines in tum ors relative to that in the contralateral brain was slight ly reduced, but did not decrease progressively with de creasing brain contamination. The mean intensity of cholines in tumors relative to that in the contralateral brain w as much higher in cases with tumor fractions of 0.7 to 0.8 or 0.9 to 1.0 than in cases with tumor fractions of 0.5 to 0.6. Therefore, in subsequent analyses, we included o n ly cases with voxels containing tumor fractions of at least 0.7.
The results in Fig. 3 indicate that the concentration o f choline is increased and that of creatine is slightly de creased in glial tumors compared to brain. The effect of the histopathological grade of the tumor on metabolite concentrations, expressed as the ratio of their peak area intensities to those of creatines in the contralateral brain, is shown in Fig. 4 and statistical comparisons are given in the figure legend. The mean intensity of cholines was sig nificantly higher in AS and AA compared to brain but not significantly higher in GBM compared to brain, The m ean intensity of creatines was the same in AS as in brain but decreased progressively with the increasing histopatho logical grade of the astrocytic tumor. The mean intensity of the NAA region was decreased in all tumor types.
The results displayed in Fig. 4 indicate that the over lap of metabolite signal intensities or of concentrations among grades of astrocytic tumors is too great to provide region in astrocytic tumors expressed as ratios to the creatine peak intensities in contralateral brain. AA = anaplastic astrocytomas; AS = astrocytomas; B = brain; GB -glioblastomas multiforme. Significance of differences (p) compared to brain: for cholines, AS 0.0014, AA 0.0002, and GB 0.1905; for creatines, AS 0.9999, AA < 0.0001, and GB 0.0001; for NAA region, AS, AA, and GB <0.0001. any diagnostic accuracy Therefore, we examined the ra tios between any two m etabolites within the same tumor and the results are sum m arized in Table 3 . All major types of glial tumors had significantly higher mean choline/ creatine and choline/N A A ratios, and a lower mean NAA/creatine ratio, compared to brain* Am ong tumor subtypes, A A had a significantly higher mean choline/cre atine ratio than AS. However, the variations and overlaps among the tum or types remained large.
The spectrum of a tum or containing lactate is shown in Fig. 5 left. It appears as a doublet 180° out of phase cen tered at 1.3 ppm. The spectrum o f a tum or containing TABLE 3 Comparison o f metabolic ratios in glial tumors to those in contralateral brain spectra in unpaired observations* t p < 0.0001; | p = 0.0264 for anaplastic astrocytoma compared to astrocytoma; § p = 0.0009; || p = 0.0358; ** p = 0.0100; t t P = 0.0003; W p = 0.0028. mobile lipids is shown in Fig. 5 right The fatty acyl-CH2 peak is at 1.3 ppm and the acyl-CH3 peak is at 0.9 ppm. Lipid signals from skull or scalp were distinguished from intratumoral lipids by: 1) a voxel position near the skull; 2) similar contamination in the contralateral brain spec trum; and 3) anomalous phase errors and/or chemical shifts. By these criteria, the small lipid signal at 1.3 ppm in the tumor shown in Fig. 2 is assumed to be contamina tion from skull or scalp. The incidences of lipids and lactate in the major tumor types are shown in Table 4 . Lipids occurred in 41% of AAs and GBMs but in only 16% of ASs. These incidences may be lower than actual ones because we did not include two cases in which it was not possible to separate lipid from lactate and 14 cases in which signals in the 0.5 to L7 ppm region, judged to have resulted only from contami nation, could have masked intratumoral lipids or lactate. The relation between lipid signal intensity and histopathological grade of astrocytic tumors is shown in Fig. 6 . The mean level of 1.3 ppm/choline in GBMs with lipids (3.2 ± 3.1 standard deviation (SD)) was higher than those in AAs with lipids (1.8 ± 1.7) and in ASs with lipids (0.5 ± 0.4; p -0.0503). Lactate was detected in only nine of the 75 astrocytic tumors and in one of the five ependy momas, and occurred in low-as well as high-grade tumors (four ASs, one AA, and four GBMs).
New and recurrent astrocytic tumors had identical mean choline/creatine (p = 0.90) and NAA/creatine ratios (p = 0.92). The 25 tumors treated with prior radiation had a mean choline/creatine ratio of 2.5, not unlike that of non radiated tumors (2.6; p = 0.77). The incidence of lactate was the same in radiated and nonradiated astrocytic tu mors (Table 4 ). Lipids occurred more frequently in radiat ed tumors (0.46) than in nonradiated ones (0.29), but this difference was not significant (p = 0.198) and may reflect the higher grade of recurrent tumors. Therefore, metabol ic changes associated with radiation did not confound our results, possibly because of the effort made to ensure the presence of viable tumor in the MR spectroscopy voxel in all cases.
Discussion
This study shows that a multiinstitutional cooperative trial of !H-M R spectroscopy is feasible. It enabled accru al of a large number of cases in a short period of time, approximately 1 year for most of the institutions. Because this was one of the first attempts to perform such a trial, o u rs has been a learning experience and the clinical qual ity assurance procedures (Fig. 1) were applied retrospec tively. This and our insistence on independent, central re view of imaging, histopathological reporting, and clinical d a ta may account for the relatively large number o f cases excluded from analysis. However, if quality-assurance cri te ria established during this study were applied prospectively rather than retrospectively and if voxel sizes small e r than 8 cc were permitted, it should be possible to increase the number of cases that could be evaluated.
The m ajor observations of this study are: 1) elevated m ean signal intensities of cholines, and decreased intensi ties of creatines and the NAA region in glial tumors com pared to contralateral brain; 2) intratumoral lipids in 41% o f higher grade (AA and GBM) astrocytic tumors, the m ean amount higher in GB than AA; and 3) infrequent occurrence of lactate with no relation to histopathological grade. The elevated choline/creatine ratio in primary glial brain tumors in general, observed here and in some studies in the literature (discussed below), is caused by increased signal intensities of cholines and decreased signal intensities o f creatines compared to brain. Con tam ination of the MR spectroscopy voxel by brain has a marked effect on metabolite intensities and ratios, but selection o f cases in which the MR spectroscopy voxel contained a relatively low amount (< 30% ) of contam ina tion did not overcome the large variations within, or over laps between, the three histopathological grades o f astro cytic tumors.
The mean metabolite ratios in contralateral brain (0.97 fo r choline/creatine and 1.78 for NAA/creatine) are sim i lar to those in the normal volunteer study53 to which each o f the institutions in our trial contributed spectra from a designated position in the parietooccipital lobe (0,81 for choline/creatine and 2.16 for NAA/creatine) and the caudate nucleus (0.95 for choline/creatine and 1.87 for NAA/creatine). The coefficients of variations are also similar to those observed in the volunteer study: 23% for choline/creatine compared to 19% in parietooccipital lobes and 20% in caudate nuclei; and 27% for NAA/crealine compared to 19% in parietooccipital lobes and 29% in caudate nuclei. This result indicates that overall technical quality control established in the volunteer study was 20 t i sie --
--
Graph showing lipids in astrocytic tumors, expressed as the ratio of intensity of the 1.3 ppm methylene peak to that of cholines (Choi). A A = anaplastic astrocytomas; AS = astrocy tomas; GBM = glioblastomas multiforme. m aintained by the institutions in this patient study. Therefore, the much greater variations of choline and cre atine m etabolite ratios observed in glial tumors may be the result o f greater metabolic differences between them. Each type and grade of tumor appears to represent a metabolically heterogeneous group.
The m icroscopic or biological basis for metabolic het erogeneity within solid or apparently viable tum or is not clear Som e astrocytic tumors are not distinct solid m ass es but rather infiltrate brain tissue27 that produces the NAA signals observed even when little evident brain is within the voxel (Fig. 3) , Many benign ASs contain foci of anaplastic cells,50,34 and GBMs containing foci of ASs have a better prognosis than GBMs not containing A S s.62 Heterogeneity of metabolic characteristics and of cellu lar necrosis in astrocytic tumors30,31 and heterogeneity of blood volum e in vivo in high-grade astrocytomas5 occur on a scale less than 0.1 ml, much smaller than the sm all est 'H-M R spectroscopy voxel currently feasible (approx imately 1 cc). Heterogeneity found over this scale could explain why studies using multiple small *H-MR spec troscopy voxels localized by two-dimensional chemical shift im aging14, 15, 20, 22 have not demonstrated less scatter within, or less overlap between, grades of glial tumors than our studies and others using single large voxels. Combinations of chemical shift imaging using m olar quantitation3,24* 29,35 and short-echo3, 12, 34, 35, 46, 60 techniques to obtain m etabolic information heretofore observed only in v/fro16, 26, 45, 59, 61 or ex y/w?30,31,51 might improve the specifici ty of 'H -M R spectroscopy. However, Preul, et a /.,47 have been able to overcome the scatter within each metabolic peak and distinguish brain tumor subtypes with very high specificity by applying a linear discriminant to analyze the patterns o f all o f the peak intensities in spectra obtained at a long (270 msec) echo time. To achieve this result, they studied only untreated cases and selected from twodim ensional chemical shift imaging datasets voxels that appeared to be most representative of viable tumor.
Some of the previous studies that focused on metabolite ratios in vivo in different histopathological grades of astro-cytic tumors reported a higher choline/creatine ratio in high-compared to low-grade tum ors,4,21,43,57,58,61 but three found this ratio unchanged11 or reduced14,32 in high grades such as GBM com pared to interm ediate grades such as A A. The mean choline/creatine ratio we observed in astrocytic tumors with m inim al brain contamination is higher than in many previous reports and is similar* to the result of Ott and colleagues4* who used a similar 'H-M R spec troscopy technique to exam ine 48 astrocytic tumors and minimized contam ination by varying voxel size to fit the region of solid, apparently viable tumor.
Comparisons betw een tumors and contralateral brain indicated that the higher mean ratios of levels o f cholines to creatines and the N A A region in AAs and GBMs compared to low er grade ASs (Table 3) is caused partly by higher concentrations o f cholines and partly by lower con centrations of creatines and of the N A A region (Fig. 4) . These results in general are in accord with those obtained in surgical specimens assayed biochem ically33 or with *H-NMR spectroscopy.16 '45,61 The low er creatine concentra tion in GBM s compared to low er grade astrocytic tumors, and the lack of a higher concentration of cholines in GBMs compared to low er grade tumors ( Fig. 4 ), were also observed in vivo in other studies in which both tumor and brain spectra were obtained from the same subjects. 11, 14, 43 The infrequent occurrence of lactate (12% of all glial tumors) and the lack o f a correlation with histopathological grade agrees with O tt and colleagues,43 who reported a definite lactate resonance in only 19% of 75 spectra from 48 astrocytic tumors. It is possible that both we and Ott and colleagues underestim ated the incidence of lactate because our techniques have a low er sensitivity to lactate than to singlet resonances and because in a few cases high lipid signals could m ask small amounts o f lactate. Kugel, et cil., 32 reported lactate in nine (41%) of 22 glial tumors, but also found that it occurred equally in low-and highgrade tumors. Fulham, et a i ,14 reported lactate in 18 (41%) of 44 glial tumors, occurring with significantly higher incidence in higher grades. However, 13 o f the 18 tumors with lactate had been treated, and the lactate was generally observed at the site o f surgery and in subacute radiation necrosis; thus in many cases viable tum or may not have been the source o f the lactate. O ur results do con tradict the conclusions o f several previous studies,2,4,8, 1 5 ,2 0 -2 2 som e 0f which m ay have overestimated the inci dence of lactate because o f their inability to distinguish lactate from lipids. M ethylene and m ethyl signals were described in glial tumors studied with *H-MR spectroscopy using short echo tim es,12,46,60 and Tzika and associates60 assigned lipids to the spectra o f virtually all childhood brain tumors of vari ous types and grades. W ith short echo times, however, these signals may also arise from proteins.6 One criterion that may be applied to help distinguish protein from lipid signals is that the latter, w hich are from fatty acyl chains, should have a relatively high ratio of the intensity of the methylene peak at 1.3 ppm com pared to that of the methyl peak at 0.9 ppm .31,51 In our cases with lipids (for example, Fig. 5 right) , this ratio averaged 5.6 ( ± 2.8 SD), and because Hie T2 relaxation times are sim ilar,31 a sim ilar ratio should occur at short echo time. By this criterion, Tzika and associates60 have greatly overestim ated the inci dence of lipids in brain tum ors and other disorders.
We have dem onstrated the presence o f mobile lipids in a significant fraction of astrocytic tumors and defined their relation to histopathological grade. These observa tions provide a correlation in vivo of the recent documen tation of lipids in 'H-NM R spectroscopy studies of intact surgical specimens of brain tumors.30,31,51 Kuesel and co workers3031 showed that the amount of mobile lipids in higher grade astrocytic tumors correlated with the amount of microscopic cellular necrosis within the specimen. The lipid signals observed by ^-M R spectroscopy arise pre dominantly from fatty acyl moieties, which are relatively mobile and probably no longer confined to membrane phospholipids. Their association with cellular necrosis in GBMs is probably due to membrane breakdown. Because we observed lipids in eight of 22 AAs, which by defini tion27 contain little or no necrosis, we suggest that mem brane breakdown may precede histologically evident necrosis. Indeed, Kuesel, et a i,30 suggested that the ap pearance of mobile lipids in regions of viable tumor indi cates metabolic effects of poor perfusion, and neutral lipid droplets were detected in the cytoplasm of hypoxic tumor cells. 13 Large amounts of lipids appear to be specific for AA or GBM, but their absence does not rule out AA or GBM, However, it is important to note that histopathological grading is imperfect in its correlation with prognosis. In adults in particular, the clinical course of lower grade tumors, more than half of which recur as, or evolve into, an aggressive phenotype, is difficult to predict.38 There fore, even if !H~MR spectroscopy metabolic characteris tics have limited diagnostic accuracy, they may have prog nostic significance, as has been found in the case of glucose hypermetabolism in PET.1,23,25,44,56 Current issues in the management of patients with AS are whether or not there is an advantage to gross-total resection and whether or not postoperative radiotherapy influences the rate of differentiation or relapse.38 A metabolic characteristic that independently correlates with malignant behavior couid help the clinician to balance the risks and benefits of aggressive therapy more accurately. Because microscopic necrosis in GBM does correlate with prognosis,9,10,41 it is possible that the presence of lipids will also. Moreover, Decause the appearance of mobile lipids appeal's to pre cede evident necrosis,30 it is possible that their presence in AAs will provide a marker for tumors likely to evolve into more aggressive behavior. Therefore, the population that has been accrued in this trial will be followed over the next few years to obtain relapse-free and overall survival statistics. This may enable us to determine if the presence of lipids or other metabolic characteristics (for example, choline concentrations that are above median vs. those below median) predicts prognosis independent o f his topathological grade.
